AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2017
Sep 20, 2017
35599_dirs_2017-09-20_a2976fdb-92d8-4a42-bb2f-c122b9f9329b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11
Reporting Person: Brughera Marco Maria (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.11 | 2023-12-30 | Common Shares (35545) | Direct | |
| Stock Option (right to buy) | $5.10 | 2024-06-27 | Common Shares (20000) | Direct |
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20